SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.20
Ask:
78.80
Spread: 3.60 (4.787%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Interim Management Statement

15 Aug 2008 07:00

RNS Number : 3935B
Accsys Technologies PLC
15 August 2008
 



15th August 2008 AIM: AXS

NYSE Euronext Amsterdam: AXS

Quarter 1 Interim Management Statement

Accsys Technologies PLC ("Accsys" or "the Company") announces its quarterly statement for the period to 30th June 2008.

The Group has made a good start to the new financial year, with continuing strong momentum despite the general economic climate.

Very positive discussions with a series of prospective licensees for the production of Accoya® wood are currently underway. The Company's first licensee, Diamond Wood China Limited ("Diamond Wood"), has further extended their commitment to the manufacture of Accoya® wood by signing an additional licence option for 250,000m3 of annual nameplate capacity in The People's Republic of China, in addition to their current licence for 500,000m3 of annual nameplate capacity that was signed last year. Progress with the development of the plant in China is on schedule.

Sales revenue for Accoya® wood, produced at the Group's plant in Arnhem, The Netherlands, increased by 38% quarter on quarter, with sales volumes increasing by 131%, due to an increase in the proportion of toll processing.

During the period the Company's global sales team was strengthened and Accoya® wood is now being shipped into North America and China, with plans in place to ship into the Middle East in the next quarter.

The Company's engineering teams have been focused on supporting the planning and development work for the construction of the Diamond Wood plant, identifying and implementing performance improvements to the Company's plant in Arnhem and carrying out tests on different wood species in the acetylation process. Work continues in building the team to ensure and reinforce worldwide coverage and distribution to meet the demand for Accoya® wood.

During the period, the Company was delighted to be included in both the Cleantech Index for companies involved in renewable technologies, and sustainablebusiness.com's new list of the World's Top 20 Sustainable Stocks. 

Overall, performance in the first quarter has been in line with the Company's expectations.

-ENDS-

For further information, please contact:

Accsys Technologies PLC

www.accsysplc.com 

William Paterson-Brown,  Executive Chairman

+44 (0) 20 8150 8838

Collins Stewart Europe Limited

Tim Mickley / Michael O'Brien

+44 (0) 20 7523 8000

Parkgreen Communications 

Leah Kramer/

Lucy Lake

+44 (0) 20 7933 8794

Citigate First Financial B.V.

Wouter van de Putte / Laurens Goverse

+ 31 (0) 20 575 4080

Notes to Editors:

Accsys Technologies PLC (www.accsysplc.com) - is an environmental science and technology company whose primary focus is on the production of Accoya® wood and technology licensing via its 100% owned subsidiary, Titan Wood (www.titanwood.com), which has manufacturing operations in Arnhem, the Netherlands, and a regional office for the Americas in Dallas, Texas. Accsys' operations comprise three principal business units: (i) the Accoya® wood production facility located in Arnhem, The Netherlands; (ii) technology development, focused on a programme of continuous improvements to the process engineering and operating protocols for the acetylation of wood which are currently under development and the development of technology for the acetylation of wood fibre; and (iii) the licensing of technology for the production of Accoya® wood across the globe.

Accoya® Wood (www.accoya.info) is produced by using a patented process that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "new wood species" via acetylation. Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Unlike most tropical and European hardwoods, its colour does not degrade when exposed to ultraviolet light. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of UV resistance, dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers.

Wood Acetylation is a process, which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. The process protects wood from rot by making it "inedible" to most micro-organisms and insects, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that when painted it requires dramatically reduced maintenance.

ACCOYA and the Trimarque Device are registered trademarks owned by Titan Wood Limited and 

may not be used or reproduced without written permission.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDGGMRMDKGRZZ
Date   Source Headline
12th Dec 20237:00 amRNSDirectorate Change
27th Nov 20239:57 amRNSNotifiable Interest - De Engh B.V.
27th Nov 20239:33 amRNSNotifiable Interest – Teslin
24th Nov 202312:21 pmRNSNotifiable Interest – De Engh B.V.
21st Nov 20233:37 pmRNSResults of Capital Raise
21st Nov 20237:04 amRNSHalf-year Report
21st Nov 20237:00 amRNSIssue of Equity
20th Sep 20235:12 pmRNSResults of Annual General Meeting 2023
15th Sep 20233:54 pmRNSNotifiable Interest - De Engh
12th Sep 20237:00 amRNSDirectorate Change
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
1st Sep 20237:00 amRNSTrading Update
1st Sep 20237:00 amRNSTotal Voting Rights
17th Aug 20235:01 pmRNSNotice of Annual General Meeting 2023
28th Jul 20237:00 amRNSDirector Interests and LTIP Awards
26th Jul 20237:00 amRNSDirectorate Appointment
21st Jul 20233:46 pmRNSAnnual Report and Financial Statements 2023
27th Jun 20237:00 amRNSPreliminary results for the year end 31 March 2023
19th Jun 202312:48 pmRNSChange of Registered Office
6th Jun 20237:00 amRNSDirectorate Update
12th May 202311:21 amRNSBlock Listing Application to AIM
3rd May 20237:00 amRNSTrading Update
4th Apr 20237:00 amRNSCEO Appointment
24th Mar 20237:00 amRNSDirectorate Appointments
2nd Mar 20236:00 pmRNSBlock Listing Six Monthly Return
2nd Mar 20236:00 pmRNSTotal Voting Rights
26th Jan 20237:00 amRNSAccsys Trading Update
15th Dec 20223:55 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSDirectorate Change
6th Dec 20223:43 pmRNSNotifiable Interest - De Engh
6th Dec 20223:36 pmRNSNotifiable Interest - Teslin Participaties
22nd Nov 20227:00 amRNSInterim Results for six months ended 30 Sept 2022
17th Nov 20222:58 pmRNSIssue of Equity
10th Nov 20224:37 pmRNSHolding(s) in Company
8th Nov 20225:09 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSUpdate on Tricoya – Consortium restructure
1st Nov 20224:12 pmRNSNotice of HY Results and Total Voting Rights
23rd Sep 20224:20 pmRNSResult of AGM
12th Sep 20227:00 amRNSAccsys Trading Update
23rd Aug 20224:49 pmRNSNotice of AGM
23rd Aug 20222:35 pmRNSBlock Listing Application to AIM
3rd Aug 20227:00 amRNSDirectorate Change
27th Jul 20225:56 pmRNSAnnual Report
12th Jul 202210:40 amRNSDirector Interests and LTIP Awards
12th Jul 202210:16 amRNSGrant of Awards under Accsys Deferred Bonus Plan
30th Jun 20227:00 amRNSPreliminary results for the year end 31 March 2022
10th Jun 20227:00 amRNSBoard Changes
1st Jun 20223:42 pmRNSNotifiable Interest – De Engh
1st Jun 20229:50 amRNSNotifiable Interest – Janus Henderson Group Plc
26th May 20222:21 pmRNSDirectors' Interest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.